The contents of the Approved Product Dossier do not change in the new AMCP Format for Formulary Dossiers, but there is so much to talk about with this type of dossier, so we will be covering it section by section in the coming weeks.
Section 3 may be the second-longest section in any dossier, as it is based on the level of evidence available for a product at the time the dossier is created or updated. Section 3 contains the clinical evidence, which is displayed through study summaries and evidence tables.
Follow our page to keep up with all of the sections of the new AMCP Format for Formulary Submissions. If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/
#AMCP #dossierwriting #managedcare